Clinical trial
Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF)…
NCT00273546 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00273546 |
|---|---|
| Title | Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer |
| Official title | A Randomized Phase III Multicenter Trial of Neoadjuvant Docetaxel (Taxotere®) Plus Cisplatin and 5-Fluorouracil (TPF) Versus Neoadjuvant Cisplatin Plus 5-Fluorouracil Followed by Concomitant Chemoradiotherapy to Improve the Overall Survival and Progression Free Survival in Patients With Locally… |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | XRP6976 (Docetaxel/Taxotere) |
| Enrollment | 500 |
| Start date | May 1, 1999 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | Jan 9, 2006 |
| Last update posted | Apr 29, 2009 |
| Countries | Argentina, Canada, France, Portugal, Russia, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: